Trade NRXP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
NRX Pharmaceuticals, Inc. (NRXP) is trading at US$3.32, up 0.91% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$154.13M. Over the past 52 weeks, NRXP has traded between US$1.62 and US$5.06. On Syfe you can trade NRXP with $0 commission and add it to your watchlist.
| Previous close | US$3.29 |
|---|---|
| Market cap | US$154.13M |
| 52-week range | US$1.62 – US$5.06 |
| Volume | 492.74K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
Year: 2021
NRX Pharmaceuticals to Submit Attestation to FDA on Packaging Deficiency for Ketamine Product
Aug 7, 7:03 PM · MT Newswires
Sector Update: Healthcare Stocks Advance Late Afternoon
Jun 24, 7:32 PM · MT Newswires
Sector Update: Healthcare
Jun 24, 7:11 PM · MT Newswires
Kadima Neuropsychiatry Institute Sues NRX Pharmaceuticals Over Breach of Acquisition Contract
Jun 24, 6:44 PM · MT Newswires
NRX Pharmaceuticals, Inc. (NRXP) stock is trading at US$3.32, +0.91% from the previous close of US$3.29.
The market cap for NRX Pharmaceuticals, Inc. (NRXP) stock is approximately US$154.13M.
The 52-week high for NRX Pharmaceuticals, Inc. (NRXP) stock is US$5.06.
The 52-week low for NRX Pharmaceuticals, Inc. (NRXP) stock is US$1.62.
NRX Pharmaceuticals, Inc. (NRXP) does not currently pay a dividend.
Stay on top of NRXP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
